Cargando…

Practical prediction model of the clinical response to programmed death-ligand 1 inhibitors in advanced gastric cancer

The identification of predictive biomarkers or models is necessary for the selection of patients who might benefit the most from immunotherapy. Seven histological features (signet ring cell [SRC], fibrous stroma, myxoid stroma, tumor-infiltrating lymphocytes [TILs], necrosis, tertiary lymphoid folli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Noh, Myung-Giun, Yoon, Youngmin, Kim, Gihyeon, Kim, Hyun, Lee, Eulgi, Kim, Yeongmin, Park, Changho, Lee, Kyung-Hwa, Park, Hansoo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080676/ https://www.ncbi.nlm.nih.gov/pubmed/33547412 http://dx.doi.org/10.1038/s12276-021-00559-1

Ejemplares similares

Staphylococcus epidermidis WF2R11 Suppresses PM(2.5)-Mediated Activation of the Aryl Hydrocarbon Receptor in HaCaT Keratinocytes
por: Lee, Eulgi, et al.
Publicado: (2022)

Lactobacillus fermentum promotes adipose tissue oxidative phosphorylation to protect against diet-induced obesity
por: Yoon, Youngmin, et al.
Publicado: (2020)

Whole-Transcriptome Sequencing Reveals Characteristics of Cancer Microbiome in Korean Patients with GI Tract Cancer: Fusobacterium nucleatum as a Therapeutic Target
por: Ahn, Hyeok, et al.
Publicado: (2022)

Bifidobacterium Strain-Specific Enhances the Efficacy of Cancer Therapeutics in Tumor-Bearing Mice
por: Yoon, Youngmin, et al.
Publicado: (2021)

Bifidobacterial carbohydrate/nucleoside metabolism enhances oxidative phosphorylation in white adipose tissue to protect against diet-induced obesity
por: Kim, Gihyeon, et al.
Publicado: (2022)

Intracellular Adhesion Molecule‐1 Improves Responsiveness to Immune Checkpoint Inhibitor by Activating CD8(+) T Cells
por: Lee, Se‐Hoon, et al.
Publicado: (2023)

Spermidine-induced recovery of human dermal structure and barrier function by skin microbiome
por: Kim, Gihyeon, et al.
Publicado: (2021)

Expression patterns of programmed death-1 and programmed death-1 ligand-1 on T cells in gastric cancer
por: Kim, Ji-Hyun, et al.
Publicado: (2019)

Status of programmed death-ligand 1 expression in sarcomas
por: Park, Hyung Kyu, et al.
Publicado: (2018)

Effect of aspirin on coronavirus disease 2019: A nationwide case-control study in South Korea
por: Son, Minkook, et al.
Publicado: (2021)

Evolution of the Tumor Microenvironment toward Immune-Suppressive Seclusion during Brain Metastasis of Breast Cancer: Implications for Targeted Therapy
por: Noh, Myung-Giun, et al.
Publicado: (2021)

Programmed cell death-ligand 1 expression predicts survival in patients with gastric carcinoma with microsatellite instability
por: Cho, Junhun, et al.
Publicado: (2017)

Programmed death-ligand 1 expression level as a predictor of EGFR tyrosine kinase inhibitor efficacy in lung adenocarcinoma
por: Kang, Minsu, et al.
Publicado: (2021)

Potential Therapeutic Skin Microbiomes Suppressing Staphylococcus aureus-Derived Immune Responses and Upregulating Skin Barrier Function-Related Genes via the AhR Signaling Pathway
por: Lee, Eulgi, et al.
Publicado: (2022)

SPON2 Is Upregulated through Notch Signaling Pathway and Promotes Tumor Progression in Gastric Cancer
por: Kang, Hyeon-Gu, et al.
Publicado: (2020)

The significance of programed cell death‐ligand 1 expression in vestibular schwannoma
por: Lee, Se A, et al.
Publicado: (2023)

Gut microbiome alterations in preclinical Alzheimer’s disease
por: Jung, Joon Hyung, et al.
Publicado: (2022)

Exosomal and Soluble Programed Death-Ligand 1 (PD-L1) Predicts Responses to Pembrolizumab in Patients with Extranodal NK/T-Cell Lymphoma
por: Kim, Seok Jin, et al.
Publicado: (2022)

Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection
por: Kwon, Mi Jung, et al.
Publicado: (2017)

Programmed death ligand-1 expression and its prognostic role in esophageal squamous cell carcinoma
por: Kim, Ryul, et al.
Publicado: (2016)

Programmed Death Ligand 1 Immunohistochemistry in Triple-Negative Breast Cancer: Evaluation of Inter-Pathologist Concordance and Inter-Assay Variability
por: Ahn, Soomin, et al.
Publicado: (2021)

Prognostic Value of Galectin-9 Relates to Programmed Death-Ligand 1 in Patients With Multiple Myeloma
por: Lee, Byung-Hyun, et al.
Publicado: (2021)

Programmed Death Ligand 1-Expressing Classical Dendritic Cells MitigateHelicobacter-Induced Gastritis
por: Go, Du-Min, et al.
Publicado: (2021)

Programmed death-ligand 1 expression in gastric adenocarcinoma is a poor prognostic factor in a high CD8+ tumor infiltrating lymphocytes group
por: Chang, Hyeyoon, et al.
Publicado: (2016)

Effect of Choline Alphoscerate on the Survival of Glioblastoma Patients: A Retrospective, Single-Center Study
por: Kim, Yeong Jin, et al.
Publicado: (2022)

Pineal Diffuse Large B-Cell Lymphoma Concomitant With Pituitary Prolactinoma: Possible Correlation Between 2 Distinguished Pathologies: A Case Report
por: Kim, Yeong-Jin, et al.
Publicado: (2016)

Prognostic Value of Serum Soluble Programmed Death-Ligand 1 and Dynamics During Chemotherapy in Advanced Gastric Cancer Patients
por: Park, Woochan, et al.
Publicado: (2021)

Chronic nicotine exposure affects programmed death-ligand 1 expression and sensitivity to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancer
por: Yeo, Chang Dong, et al.
Publicado: (2019)

Impact of programmed death‐ligand 1 (PD‐L1) positivity on clinical and molecular features of patients with metastatic gastric cancer
por: Shin, Minkyue, et al.
Publicado: (2023)

Club cell-specific role of programmed cell death 5 in pulmonary fibrosis
por: Park, Soo-Yeon, et al.
Publicado: (2021)

Association of Galectin 9 Expression with Immune Cell Infiltration, Programmed Cell Death Ligand-1 Expression, and Patient’s Clinical Outcome in Triple-Negative Breast Cancer
por: Ju, Mi-Ha, et al.
Publicado: (2021)

An Experimental Infarct Targeting the Internal Capsule: Histopathological and Ultrastructural Changes
por: Han, Chang-Woo, et al.
Publicado: (2017)

Antagonizing programmed death-1 and programmed death ligand-1 as a therapeutic approach for gastric cancer
por: Liu, Xiaojun, et al.
Publicado: (2016)

Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas
por: Yang, Min-Wei, et al.
Publicado: (2019)

Frequency and Prognostic Value of IDH Mutations in Korean Patients With Cholangiocarcinoma
por: Kim, Nah Ihm, et al.
Publicado: (2020)

Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma
por: Ock, Chan-Young, et al.
Publicado: (2017)

Programmed death-ligand 1 (PD-L1) expression in tumour cell and tumour infiltrating lymphocytes of HER2-positive breast cancer and its prognostic value
por: Kim, Ahrong, et al.
Publicado: (2017)

KITENIN promotes aerobic glycolysis through PKM2 induction by upregulating the c-Myc/hnRNPs axis in colorectal cancer
por: Varlı, Mücahit, et al.
Publicado: (2023)

Inhibition of Programmed Death Receptor-1/Programmed Death Ligand-1 Interactions by Ginsenoside Metabolites
por: Yim, Nam-Hui, et al.
Publicado: (2020)

Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves’ Disease and Hashimoto’s Thyroiditis in Korean Patients
por: Yoon, Jee Hee, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i1cs6cf70j8pblmdc19q0rnj0n